Lori McIntyre

Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels

James N. Kochenderfer, Robert Somerville, Tangying Lu et al. · Journal of Clinical Oncology · 2017 · 561 citations

Medicine, Hematology, Immunology +17

Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma

Stephanie L. Goff, Richard A. Morgan, James C. Yang et al. · Journal of Immunotherapy · 2019 · 376 citations · Full text

Medicine, Immunology, Oncology +16

Long-Term Follow-Up of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy

Kathryn M. Cappell, Richard M. Sherry, James C. Yang et al. · Journal of Clinical Oncology · 2020 · 308 citations · Full text

Medicine, Hematology, Oncology +16

Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy

James N. Kochenderfer, Robert Somerville, Tangying Lu et al. · Molecular Therapy · 2017 · 280 citations · Full text

Medicine, Hematology, Oncology +17

Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial

Frank J. Lowery, Stephanie L. Goff, Billel Gasmi et al. · Nature Medicine · 2025 · 48 citations · Full text

Life Sciences, Immunology, Oncology +16